简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:India stocks extended losses as investors reassessed the prospect of further gains amid a gloomy economic outlook.
India stocks extended losses as investors reassessed the prospect of further gains amid a gloomy economic outlook.
The S&P BSE Sensex lost 0.5% to 37,847.60 as of 10:06 a.m. in Mumbai after its steepest slide in two weeks yesterday sent it below the 50-day moving average, signaling to some investors that theres further losses to come. The NSE Nifty 50 Index dropped 0.6%.
“Investors are concerned about economic growth, particularly since stocks are trading at levels close to where they were pre-pandemic,” said Chokkalingam G, chief investment officer at Equinomics Research & Advisory Ltd. in Mumbai.
{8}
Until yesterdays losses, the Sensex had surged 50% from its coronavirus pandemic-triggered low in March to within striking distance of the January record high even as Indian coronavirus cases continued to surge to the second-highest globally and the economy faces its steepest ever contraction.
{8}
As Indian stocks head toward their worst month in four, some equity funds may be diverted by a revival in initial public offerings. Computer Age Management Services Pvt. Ltd. aims to raise as much as 22.4 billion rupees ($305 million), while Chemcon Specialty Chemicals Pvt. Ltd. is seeking 1.65 billion rupees, with both offers closing Wednesday. Stock broker Angel Broking Ltd. plans to raise 3 billion rupees in an offering through Thursday.
The yield on the benchmark 10-year government bond was little changed at 6.02%, while the rupee weakened 0.1% to 73.5063 against the U.S. dollar.
{13}
The Numbers
{13}{14}
All 19 sector sub-indexes compiled by BSE Ltd. fell, led by a gauge of real estate companies
{14}
Reliance Industries Ltd. was the biggest drag on the Sensex, while Tata Steel Ltd. was the biggest loser, slipping 3%
Related Stories
Remittance Boom Is Turning Into a Bust for Asia Emerging Markets
Vaccine Likely to be Ready for India Next Year, Scientist Says
Is It Enough? Tracking Major Economies Stimulus Measures
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.